全志科技(300458.SZ)業績快報:2022年度淨利同比下降57.25%
格隆匯2月24日丨全志科技(300458.SZ)披露2022年度業績快報,報吿期內,公司實現營業收入15.14億元,同比下降26.69%,歸屬於上市公司股東的淨利潤2.11億元,同比下降57.25%。影響經營業績的主要因素有:
(1)報吿期內,由於受到多地疫情反覆、地緣政治風險等影響,消費電子市場需求疲弱,導致公司營業收入同比下降26.69%;
(2)報吿期內,公司持續加大研發投入,積極推動工業及汽車電子相關領域新產品平台的研發項目,增量研發資源的投入導致研發支出同比增長8.77%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.